Huadong Medicine Co., Ltd

SZSE:000963 Voorraadrapport

Marktkapitalisatie: CN¥57.5b

Huadong Medicine Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Huadong Medicine has been growing earnings at an average annual rate of 0.9%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 4.6% per year. Huadong Medicine's return on equity is 14.2%, and it has net margins of 7.7%.

Belangrijke informatie

0.9%

Groei van de winst

0.9%

Groei van de winst per aandeel

Healthcare Groei van de industrie7.0%
Inkomstengroei4.6%
Rendement op eigen vermogen14.2%
Nettomarge7.7%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

Recent updates

There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Sep 23
There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Aug 05
Earnings Working Against Huadong Medicine Co., Ltd's (SZSE:000963) Share Price

Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

Jun 28
Huadong Medicine (SZSE:000963) Seems To Use Debt Rather Sparingly

There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Jun 10
There Are Reasons To Feel Uneasy About Huadong Medicine's (SZSE:000963) Returns On Capital

Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Apr 21
Huadong Medicine Co., Ltd (SZSE:000963) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year

Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Apr 08
Market Cool On Huadong Medicine Co., Ltd's (SZSE:000963) Earnings

Is Huadong Medicine (SZSE:000963) A Risky Investment?

Mar 16
Is Huadong Medicine (SZSE:000963) A Risky Investment?

Opbrengsten en kosten

Hoe Huadong Medicine geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

SZSE:000963 Opbrengsten, kosten en inkomsten (CNY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 2441,7073,2128,2461,379
30 Jun 2441,2043,1018,2971,356
31 Mar 2440,9202,9468,0281,287
31 Dec 2340,6242,8398,0911,271
30 Sep 2340,2512,7077,9281,069
30 Jun 2339,9022,5927,8171,008
31 Mar 2338,8972,5507,889962
01 Jan 2337,7152,4997,6521,016
30 Sep 2236,4942,3887,1041,040
30 Jun 2235,5822,3426,7581,109
31 Mar 2234,5992,2486,4431,079
01 Jan 2234,5632,3026,633980
30 Sep 2134,1102,3246,675964
30 Jun 2134,2022,3896,898885
31 Mar 2133,9822,4316,810883
31 Dec 2033,6832,8206,992927
30 Sep 2033,3192,9916,8911,051
30 Jun 2033,8582,9486,9231,084
31 Mar 2034,3393,0536,9641,179
31 Dec 1935,4462,8136,9211,073
30 Sep 1935,0872,6716,615952
30 Jun 1933,5872,5706,092911
31 Mar 1932,5322,5155,706771
31 Dec 1830,6632,2675,132706
30 Sep 1829,5852,0994,978652
30 Jun 1829,0662,0314,690726
31 Mar 1828,5191,8954,554555
31 Dec 1727,8321,7804,359462
30 Sep 1727,9111,7404,298276
30 Jun 1727,2271,6654,3710
31 Mar 1726,3631,5564,2540
31 Dec 1625,3801,4474,0960
30 Sep 1624,4911,3654,0740
30 Jun 1623,5881,2533,9780
31 Mar 1622,6821,1883,7490
31 Dec 1521,7271,0973,5120
30 Sep 1520,9231,1363,2920
30 Jun 1520,2201,0343,0670
31 Mar 1519,6568992,9970
31 Dec 1418,9477572,7720
30 Sep 1418,2086552,6720
30 Jun 1417,7246312,5200
31 Mar 1417,2376172,3950
31 Dec 1316,7185752,2670

Kwaliteitswinsten: 000963 has high quality earnings.

Groeiende winstmarge: 000963's current net profit margins (7.7%) are higher than last year (6.7%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: 000963's earnings have grown by 0.9% per year over the past 5 years.

Versnelling van de groei: 000963's earnings growth over the past year (18.7%) exceeds its 5-year average (0.9% per year).

Winst versus industrie: 000963 earnings growth over the past year (18.7%) exceeded the Healthcare industry -5.7%.


Rendement op eigen vermogen

Hoge ROE: 000963's Return on Equity (14.2%) is considered low.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden